Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Rationale and clinical results of inhibiting interleukin-5 for the treatment of severe asthma.

Berair R, Pavord ID.

Curr Allergy Asthma Rep. 2013 Oct;13(5):469-76. doi: 10.1007/s11882-013-0379-3. Review.

PMID:
23904099
[PubMed - indexed for MEDLINE]
2.

Anti-interleukin-5 monoclonal antibodies: preclinical and clinical evidence in asthma models.

Leckie MJ.

Am J Respir Med. 2003;2(3):245-59. Review.

PMID:
14720006
[PubMed - indexed for MEDLINE]
3.

Subclinical phenotypes of asthma.

Bradding P, Green RH.

Curr Opin Allergy Clin Immunol. 2010 Feb;10(1):54-9. doi: 10.1097/ACI.0b013e32833489a9. Review.

PMID:
19907311
[PubMed - indexed for MEDLINE]
4.

Eosinophils and interleukin-5: the debate continues.

Kay AB, Menzies-Gow A.

Am J Respir Crit Care Med. 2003 Jun 15;167(12):1586-7. Review. No abstract available.

PMID:
12796050
[PubMed - indexed for MEDLINE]
5.
6.

Monoclonal antibodies for the treatment of refractory asthma.

Hambly N, Nair P.

Curr Opin Pulm Med. 2014 Jan;20(1):87-94. doi: 10.1097/MCP.0000000000000007. Review.

PMID:
24275927
[PubMed - indexed for MEDLINE]
7.

Inhibition of interleukin-5 with a monoclonal antibody attenuates allergic inflammation.

Danzig M, Cuss F.

Allergy. 1997 Aug;52(8):787-94. Review.

PMID:
9284977
[PubMed - indexed for MEDLINE]
8.

Anti-interleukin-5 antibody therapy in asthma and allergies.

Corren J.

Curr Opin Allergy Clin Immunol. 2011 Dec;11(6):565-70. doi: 10.1097/ACI.0b013e32834c3d30. Review.

PMID:
21971335
[PubMed - indexed for MEDLINE]
9.

Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice.

Hogan SP, Koskinen A, Foster PS.

Immunol Cell Biol. 1997 Jun;75(3):284-8.

PMID:
9243294
[PubMed - indexed for MEDLINE]
Free Article
10.

Anti-interleukin-5 therapy in severe asthma.

Garcia G, Taillé C, Laveneziana P, Bourdin A, Chanez P, Humbert M.

Eur Respir Rev. 2013 Sep 1;22(129):251-7. doi: 10.1183/09059180.00004013. Review.

PMID:
23997052
[PubMed - indexed for MEDLINE]
Free Article
11.

Targeting interleukin (IL) 5 for asthma and hypereosinophilic diseases.

Stein ML, Munitz A.

Recent Pat Inflamm Allergy Drug Discov. 2010 Nov;4(3):201-9. Review.

PMID:
20807192
[PubMed - indexed for MEDLINE]
12.

Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease.

Greenfeder S, Umland SP, Cuss FM, Chapman RW, Egan RW.

Respir Res. 2001;2(2):71-9. Epub 2001 Mar 8. Review.

PMID:
11686868
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Mepolizumab in eosinophilic disorders.

Abonia JP, Putnam PE.

Expert Rev Clin Immunol. 2011 Jul;7(4):411-7. doi: 10.1586/eci.11.27. Review.

PMID:
21790283
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Anti-interleukin-5 antibody therapy in eosinophilic diseases.

Simon D, Braathen LR, Simon HU.

Pathobiology. 2005;72(6):287-92. Review.

PMID:
16582580
[PubMed - indexed for MEDLINE]
15.

[Anti-interleukin-5 therapy for eosinophilic diseases].

Simon D, Braathen LR, Simon HU.

Hautarzt. 2007 Feb;58(2):122, 124-7. Review. German.

PMID:
17221241
[PubMed - indexed for MEDLINE]
16.

A role for eosinophils in airway remodelling in asthma.

Kay AB, Phipps S, Robinson DS.

Trends Immunol. 2004 Sep;25(9):477-82. Review.

PMID:
15324740
[PubMed - indexed for MEDLINE]
17.

A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma.

Busse WW, Ring J, Huss-Marp J, Kahn JE.

J Allergy Clin Immunol. 2010 Apr;125(4):803-13. doi: 10.1016/j.jaci.2009.11.048. Review.

PMID:
20371394
[PubMed - indexed for MEDLINE]
18.

Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.

Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O'Byrne PM.

N Engl J Med. 2009 Mar 5;360(10):985-93. doi: 10.1056/NEJMoa0805435.

PMID:
19264687
[PubMed - indexed for MEDLINE]
Free Article
19.

Anti-interleukin-5 therapy and severe asthma.

Gleich GJ.

N Engl J Med. 2009 Jun 11;360(24):2577; author reply 2578. No abstract available.

PMID:
19522047
[PubMed - indexed for MEDLINE]
20.

Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study.

Kips JC, O'Connor BJ, Langley SJ, Woodcock A, Kerstjens HA, Postma DS, Danzig M, Cuss F, Pauwels RA.

Am J Respir Crit Care Med. 2003 Jun 15;167(12):1655-9. Epub 2003 Mar 20.

PMID:
12649124
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk